Key facts
- This page summarizes Sandra E. Rowland's Form 4 filing for Xylem Inc. (XYL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Mar 2022, 15:54.
Sandra E. Rowland - 01 Mar 2022 Form 4 Insider Report for Xylem Inc. (XYL)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- XYL
- Reported as of
- 01 Mar 2022
- Net transaction value
- -$42,946
- SEC form
- 4
- Accepted by SEC
- 03 Mar 2022, 15:54:48 UTC
- Prior SEC filing
- 02 Mar 2022
- Next SEC filing
- 28 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kimberly Rehm, by power of attorney for Sandra E Rowland
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sandra E. Rowland filed Form 4 for Xylem Inc. (XYL) on 03 Mar 2022.
Change
- Previous filing in this sequence was filed on 02 Mar 2022.
- Current net transaction value: -$42,946.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XYL
transaction
Common Stock
Tax liability
- Transaction value
- $42,946
- Shares
- -495
- Change %
- -6.3%
- Price
- $86.76
- Shares after
- 7,339
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F1
XYL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,899
- Change %
- +67%
- Price
- $0.000000
- Shares after
- 12,238
- Date
- 01 Mar 2022
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
XYL
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +21,400
- Change %
- Price
- $0.000000
- Shares after
- 21,400
- Date
- 01 Mar 2022
- Ownership
- Direct
- Underlying class
- Common
- Underlying amount
- 21,400
- Exercise price
- $86.76
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects the withholding of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan
Footnote F2
Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan, that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025
Footnote F3
Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan that are scheduled to vest in one third increments on March 1, 2023, March 1, 2024 and March 1, 2025.